Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kalra

Showing results (181-190 of 193) with videos related to

Pageof 20
Sort By:
American Journal of Nephrology|June 29, 2025
Effects of Ferric Derisomaltose in Heart Failure with Iron Deficiency according to Renal Function in the IRONMAN Randomised Controlled TrialFozia Z Ahmed, Paul R Kalra, John G F Cleland, et al.
European Journal of Heart Failure|March 17, 2026
Long-term Safety and Performance of an Implantable IVC Sensor for Congestion-Guided Management in Heart Failure: 12-Month Results from the FUTURE-HF Trial PortfolioKevin Damman, Nir Uriel, Mandeep R Mehra, et al.
European Journal of Heart Failure|October 25, 2024
Effect of correcting iron deficiency on the risk of serious infection in heart failure: Insights from the IRONMAN trialPaul W Foley, Paul R Kalra, John G F Cleland, et al.
Journal of the American College of Cardiology|October 23, 2024
Adjudication of Hospitalizations and Deaths in the IRONMAN Trial of Intravenous Iron for Heart FailureJohn G F Cleland, Pierpaolo Pellicori, Fraser J Graham, et al.
European Heart Journal|March 6, 2024
Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trialJohn G F Cleland, Philip A Kalra, Pierpaolo Pellicori, et al.
European Journal of Heart Failure|May 14, 2024
Measuring congestion with a non-invasive monitoring device in heart failure and haemodialysis: CONGEST-HFJames P Curtain, Atefeh Talebi, Alasdair McIntosh, et al.
JACC. Heart Failure|April 10, 2025
First-in-Human Implantable Inferior Vena Cava Sensor for Remote Care in Heart Failure: FUTURE-HFPaul R Kalra, Irakli Gogorishvili, George Khabeishvili, et al.
Lancet (London, England)|November 8, 2022
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trialPaul R Kalra, John G F Cleland, Mark C Petrie, et al.
Acta Cardiologica|September 11, 2023
Effectiveness of out-patient based acute heart failure care: a pilot randomised controlled trialK Y K Wong, D A Hughes, M Debski, et al.
Clinical Medicine (London, England)|April 1, 2026
Renin-Angiotensin System inhibitors (RASi) are not nephrotoxic - they protect the kidneys and the heartJonathan S Murray, Paul R Kalra, Lisa J Anderson, et al.
Pageof 20

Showing results (181-190 of 193) with videos related to

Sort By:
Pageof 20
American Journal of Nephrology|June 29, 2025
Effects of Ferric Derisomaltose in Heart Failure with Iron Deficiency according to Renal Function in the IRONMAN Randomised Controlled TrialFozia Z Ahmed, Paul R Kalra, John G F Cleland, et al.
European Journal of Heart Failure|March 17, 2026
Long-term Safety and Performance of an Implantable IVC Sensor for Congestion-Guided Management in Heart Failure: 12-Month Results from the FUTURE-HF Trial PortfolioKevin Damman, Nir Uriel, Mandeep R Mehra, et al.
European Journal of Heart Failure|October 25, 2024
Effect of correcting iron deficiency on the risk of serious infection in heart failure: Insights from the IRONMAN trialPaul W Foley, Paul R Kalra, John G F Cleland, et al.
Journal of the American College of Cardiology|October 23, 2024
Adjudication of Hospitalizations and Deaths in the IRONMAN Trial of Intravenous Iron for Heart FailureJohn G F Cleland, Pierpaolo Pellicori, Fraser J Graham, et al.
European Heart Journal|March 6, 2024
Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trialJohn G F Cleland, Philip A Kalra, Pierpaolo Pellicori, et al.
European Journal of Heart Failure|May 14, 2024
Measuring congestion with a non-invasive monitoring device in heart failure and haemodialysis: CONGEST-HFJames P Curtain, Atefeh Talebi, Alasdair McIntosh, et al.
JACC. Heart Failure|April 10, 2025
First-in-Human Implantable Inferior Vena Cava Sensor for Remote Care in Heart Failure: FUTURE-HFPaul R Kalra, Irakli Gogorishvili, George Khabeishvili, et al.
Lancet (London, England)|November 8, 2022
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trialPaul R Kalra, John G F Cleland, Mark C Petrie, et al.
Acta Cardiologica|September 11, 2023
Effectiveness of out-patient based acute heart failure care: a pilot randomised controlled trialK Y K Wong, D A Hughes, M Debski, et al.
Clinical Medicine (London, England)|April 1, 2026
Renin-Angiotensin System inhibitors (RASi) are not nephrotoxic - they protect the kidneys and the heartJonathan S Murray, Paul R Kalra, Lisa J Anderson, et al.
Pageof 20